Showing results (121-130 of 136) with videos related to
Sort By:
Pageof 14
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 29, 2008
Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancerHye Jin Choi, Nam-Kyu Kim, Ki Chang Keum, et al.Journal of Gastric Cancer|April 6, 2026
Molecular and Phenotypic Characterization of Fluid-Derived Patient-Derived Cell and Organoid Models in Advanced Gastric CancerYe Jin Moon, Woo Sun Kwon, Chan Hee Park, et al.Cancer Research and Treatment|May 5, 2026
A Phase Ib/II Study of Pemigatinib in Combination with Paclitaxel in Patients with Gastric Cancer with FGFs/FGFRs AlterationsMinkyu Jung, Soo Hyun Park, Hyoyoung Kim, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 10, 2010
Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancerSang Joon Shin, Nam Kyu Kim, Ki Chang Keum, et al.European Journal of Cancer (Oxford, England : 1990)|July 15, 2022
Hyperprogressive disease during PD-1 blockade in patients with advanced gastric cancerChang Gon Kim, Moonki Hong, Hei-Cheul Jeung, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer StudyChoong-Kun Lee, Hyo Song Kim, Minkyu Jung, et al.Cancer Chemotherapy and Pharmacology|August 29, 2012
A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02Yoon Hee Choi, Sang Cheul Oh, Jun Suk Kim, et al.Experimental Cell Research|November 20, 2021
PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancerHei-Cheul Jeung, Roisin Puentes, Alexander Aleshin, et al.British Journal of Cancer|October 13, 2017
ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancerIkhyun Jun, Hyung Soon Park, He Piao, et al.Nature Communications|October 12, 2022
A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancerChoong-Kun Lee, Sun Young Rha, Hyo Song Kim, et al.Pageof 14